Literature DB >> 18542759

Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: Time to write the obituary?

Malcolm J Moore1.   

Abstract

Entities:  

Year:  2007        PMID： 18542759      PMCID： PMC2422916          DOI： 10.5489/cuaj.36

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  4 in total

1.  Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

Authors:  M E Gleave; M Elhilali; Y Fradet; I Davis; P Venner; F Saad; L H Klotz; M J Moore; V Paton; A Bajamonde
Journal:  N Engl J Med       Date:  1998-04-30       Impact factor: 91.245

2.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

3.  Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guideline.

Authors:  Sebastien Hotte; Tricia Waldron; Christina Canil; Eric Winquist
Journal:  Can Urol Assoc J       Date:  2007-03       Impact factor: 1.862

4.  Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Authors:  G Fyfe; R I Fisher; S A Rosenberg; M Sznol; D R Parkinson; A C Louie
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544
  4 in total
  1 in total

1.  Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence.

Authors:  Ping Niu; Aibek Smagul; Lu Wang; Aiman Sadvakas; Ying Sha; Laura M Pérez; Aliya Nussupbekova; Aday Amirbekov; Akan A Akanov; Beatriz G Gálvez; I King Jordan; Victoria V Lunyak
Journal:  Oncotarget       Date:  2015-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.